RxDoctor Payments Data

Jorge Monroy Avella

General Practice · Ocoee, FLNPI 1265860225

Payments from drug & device makers

What this record shows

Modernatx, Inc. accounts for 87.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $1,390 and has fallen 98.8% since, to $16 in 2025.

$1,595in general payments, 2019–2025

Across 9 payments — averaging $177.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$1K
  • Merck$135
  • Sanofi US Services Inc.$54
  • Shield Therapeutics Inc$16
$10,566,301in research payments, 2019–2025

Across 938 payments — averaging $11,265 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$9.2M
  • Bavarian Nordic A/s$892K
  • Sanofi Pasteur Inc.$155K
  • E.r. Squibb & Sons, L.L.C.$114K
  • Pfizer$55K
  • Mylan Specialty L.p.$51K
  • plus $83K from 2 others

What the payments were for

  • Travel & lodging$88355%
  • Food & beverage$71245%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,595 in reported general payments places this provider in the 85th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium16$150
Atorvastatin Calcium14$102
Metformin Hcl18$32

Paid to pharmacies, not to this prescriber.

Other general practice in Ocoee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →